| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |